Search Results - "Cosio, F.G."

Terminal Complement Inhibition Decreases Antibody‐Mediated Rejection in Sensitized Renal Transplant Recipients by Stegall, M. D., Diwan, T., Raghavaiah, S., Cornell, L. D., Burns, J., Dean, P. G., Cosio, F. G., Gandhi, M. J., Kremers, W., Gloor, J. M.

“…Sensitized renal transplant recipients with high levels of donor‐specific alloantibody (DSA) commonly develop antibody‐mediated rejection (AMR), which may…”
Get full text

Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1‐Year Protocol Biopsies by Cosio, F. G., El Ters, M., Cornell, L. D., Schinstock, C. A., Stegall, M. D.

“…Allograft histology 1 year posttransplant is an independent correlate to long‐term death‐censored graft survival. We assessed prognostic implications of…”
Get full text

Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation by Gloor, J. M., Winters, J. L., Cornell, L. D., Fix, L. A., DeGoey, S. R., Knauer, R. M., Cosio, F. G., Gandhi, M. J., Kremers, W., Stegall, M. D.

“…Renal transplant candidates with donor‐specific alloantibody (DSA) have increased risk of antibody‐mediated allograft injury. The goal of this study was to…”
Get full text

Patient Survival and Cardiovascular Risk After Kidney Transplantation: The Challenge of Diabetes by Cosio, F. G., Hickson, L. J., Griffin, M. D., Stegall, M. D., Kudva, Y.

“…An increasing proportion of kidney recipients have diabetes mellitus (DM). Herein, we assessed the impact of DM on morbidity and mortality. The study included…”
Get full text

Rituximab treatment of idiopathic membranous nephropathy by Fervenza, F.C., Cosio, F.G., Erickson, S.B., Specks, U., Herzenberg, A.M., Dillon, J.J., Leung, N., Cohen, I.M., Wochos, D.N., Bergstralh, E., Hladunewich, M., Cattran, D.C.

“…Idiopathic membranous nephropathy is a common cause of nephrotic syndrome whose pathogenesis may involve B-cell functions. Rituximab is a monoclonal antibody…”
Get full text

Urine High and Low Molecular Weight Proteins One‐Year Post‐Kidney Transplant: Relationship to Histology and Graft Survival by Amer, H., Lieske, J. C., Rule, A. D., Kremers, W. K., Larson, T. S., Palacios, C. R. Franco, Stegall, M. D., Cosio, F. G.

“…Increased urinary protein excretion is common after renal transplantation and portends worse outcome. In this study we assessed the prognostic contribution of…”
Get full text

Recurrent Idiopathic Membranous Nephropathy After Kidney Transplantation: A Surveillance Biopsy Study by Dabade, T. S., Grande, J. P., Norby, S. M., Fervenza, F. C., Cosio, F. G.

“…Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. MN can recur after kidney transplantation causing proteinuria, allograft…”
Get full text

Histologic Findings One Year After Positive Crossmatch or ABO Blood Group Incompatible Living Donor Kidney Transplantation by Gloor, J. M., Cosio, F. G., Rea, D. J., Wadei, H. M., Winters, J. L., Moore, S. B., DeGoey, S. R., Lager, D. J., Grande, J. P., Stegall, M. D.

“…Recent protocols have allowed successful positive crossmatch (+XM) and ABO incompatible (ABOI) kidney transplantation, although their long‐term outcome is not…”
Get full text

The Pathology and Clinical Features of Early Recurrent Membranous Glomerulonephritis by Rodriguez, E. F., Cosio, F. G., Nasr, S. H., Sethi, S., Fidler, M. E., Stegall, M. D., Grande, J. P., Fervenza, F. C., Cornell, L. D.

“…We assessed the earliest manifestations of recurrent membranous glomerulonephritis (MGN) in renal allografts. Clinical, laboratory and pathologic data were…”
Get full text

Renal Allograft Outcome after Simultaneous Heart and Kidney Transplantation by Grupper, A, Hathcock, M.A, Cosio, F.G, Edwards, B.S, Kushwaha, S.S

Get full text

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative by Kasiske, B., Cosio, F.G., Beto, J., Bolton, K., Chavers, B.M., Grimm, R., Levin, A., Masri, B., Parekh, R., Wanner, C., Wheeler, D.C., Wilson, P.W.F.

“…The incidence of cardiovascular disease (CVD) is very high in patients with chronic kidney (CKD) disease and in kidney transplant recipients. Indeed, available…”
Get full text

Glomerular volume and renal histology in obese and non-obese living kidney donors by Rea, D.J., Heimbach, J.K., Grande, J.P., Textor, S.C., Taler, S.J., Prieto, M., Larson, T.S., Cosio, F.G., Stegall, M.D.

“…The link between obesity and renal disease is unclear, and there is no consensus as to whether obese individuals are at increased risk for kidney disease after…”
Get full text

Kidney Transplant Function and Histological Clearance of Virus Following Diagnosis of Polyomavirus‐Associated Nephropathy (PVAN) by Wadei, H. M., Rule, A. D., Lewin, M., Mahale, A. S., Khamash, H. A., Schwab, T. R., Gloor, J. M., Textor, S. C., Fidler, M. E., Lager, D. J., Larson, T. S., Stegall, M. D., Cosio, F. G., Griffin, M. D.

“…Polyomavirus‐associated nephropathy (PVAN) is managed by reduced immunosuppression with or without antiviral therapy. Data from 55 patients with biopsy‐proven…”
Get full text

Kidney Allograft Inflammation and Fibrosis, Causes and Consequences by GAGO, M, CORNELL, L. D, KREMERS, W. K, STEGALL, M. D, COSIO, F. G

Get full text

Living Donor Age and Kidney Transplant Outcomes by NOPPAKUN, K, COSIO, F. G, DEAN, P. G, TALER, S. J, WAUTERS, R, GRANDE, J. P

Get full text

Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury by Stegall, M. D., Cornell, L. D., Park, W. D., Smith, B. H., Cosio, F. G.

“…Improving long‐term renal allograft survival remains an important unmet need. To assess the extent of histologic injury at 10 years after transplantation in…”
Get full text

Identifying Specific Causes of Kidney Allograft Loss by El‐Zoghby, Z. M., Stegall, M. D., Lager, D. J., Kremers, W. K., Amer, H., Gloor, J. M., Cosio, F. G.

“…The causes of kidney allograft loss remain unclear. Herein we investigated these causes in 1317 conventional kidney recipients. The cause of graft loss was…”
Get full text

Kidney Allograft Survival After Acute Rejection, the Value of Follow‐Up Biopsies by El Ters, M., Grande, J. P., Keddis, M. T., Rodrigo, E., Chopra, B., Dean, P. G., Stegall, M. D., Cosio, F. G.

“…Kidney allografts are frequently lost due to alloimmunity. Still, the impact of early acute rejection (AR) on long‐term graft survival is debated. We examined…”
Get full text

Transplant Glomerulopathy by Cosio, F. G., Gloor, J. M., Sethi, S., Stegall, M. D.

“…Transplant glomerulopathy (TG) is a histologic entity described more than four decades ago. In the last few years, our understanding of TG has improved…”
Get full text

Anti‐Phospholipase A2 Receptor Antibodies in Recurrent Membranous Nephropathy by Kattah, A., Ayalon, R., Beck, L. H., Sethi, S., Sandor, D. G., Cosio, F. G., Gandhi, M. J., Lorenz, E. C., Salant, D. J., Fervenza, F. C.

“…About 70% of patients with primary membranous nephropathy (MN) have circulating anti‐phospholipase A2 receptor (PLA2R) antibodies that correlate with disease…”
Get full text